Bronchial Thermoplasty is a frontrunner in the newest asthma treatment available. Not all patients are candidates for this new FDA-approved treatment, but for those who do qualify, Bronchial Thermoplasty has been shown to significantly reduce the frequency of exacerbations (onset of conditions) and emergency room visits, as well as improve quality of life for patients whose severe asthma is not controlled well with high-dose inhaled steroids and long-acting bronchodilators. Three separate outpatient procedures involve the use of radiofrequency energy applied to the thickened muscle wall in the airways, which decreases the constricting effect of that muscle, maintaining a larger opening for easier breathing.
Bronchial Thermoplasty is a non-drug minimally-invasive bronchoscopic procedure for severe persistent asthma in patients 18 years and older whose asthma is not well controlled with inhaled corticosteroids and long-acting beta-agonists. After all three procedures are performed; the bronchial thermoplasty treatment is complete.
“We are excited to be one of the first hospitals in the area able to offer this new procedure,” states Deborah’s Pulmonary Chair, Dr. Andrew Martin. “As we roll out the use of bronchial thermoplasty, I am sure that we will see terrific results in severe asthma sufferers, who will see the quality of their day-to-day lives dramatically improve. Severe asthma sufferers can be referred to Deborah Heart and Lung Center by their primary care physician or pulmonologist to determine whether they are a candidate for this new procedure.”